deltatrials
Terminated PHASE3 INTERVENTIONAL 3-arm NCT00809783

Extension Study Of Tanezumab In Osteoarthritis

A PHASE 3, MULTICENTER, RANDOMIZED, LONG TERM STUDY OF THE SAFETY OF TANEZUMAB IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE OR HIP

Sponsor: Pfizer

Conditions Osteoarthritis
Interventions tanezumab
Updated 10 times since 2017 Last updated: Apr 14, 2021 Started: Feb 6, 2009 Primary completion: Nov 2, 2010 Completion: Jun 23, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

See termination reason in detailed description.

Listed as NCT00809783, this PHASE3 trial focuses on Osteoarthritis and remains terminated or withdrawn. Sponsored by Pfizer, it has been updated 10 times since 2009, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotTerminated~Jun 2018 – ~Jul 2019 · 13 months · monthly snapshotTerminated~Jul 2019 – ~Jan 2021 · 18 months · monthly snapshotTerminated~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshotTerminated~Jun 2021 – ~Dec 2021 · 6 months · monthly snapshotTerminated~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 11 months · monthly snapshotTerminated

Change History

10 versions recorded
  1. Sep 2025 — Present [monthly]

    Terminated PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  4. Dec 2021 — Jul 2024 [monthly]

    Terminated PHASE3

  5. Jun 2021 — Dec 2021 [monthly]

    Terminated PHASE3

Show 5 earlier versions
  1. Jan 2021 — Jun 2021 [monthly]

    Terminated PHASE3

  2. Jul 2019 — Jan 2021 [monthly]

    Terminated PHASE3

  3. Jun 2018 — Jul 2019 [monthly]

    Terminated PHASE3

  4. Feb 2017 — Jun 2018 [monthly]

    Terminated PHASE3

  5. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE3

    First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Pfizer
Data source: Pfizer

For direct contact, visit the study record on ClinicalTrials.gov .